Prurigo Nodularis Clinical Trials

This is a research study of an investigational drug called serlopitant, which is being tested for the treatment of pruritus in people with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  Pruritus, also called itch, is defined as ...

A research study is evaluating an investigational medication for Prurigo Nodularis (PN), a condition characterized by intensely itchy nodules on the skin. Those with PN often find that scratching does not relieve the itch.

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  All enrolled subjects will receive ...

The PRISM Study is for adults 18 years of age and older who have been diagnosed with Prurigo Nodularis. The purpose of this study, is to test the safety and effectiveness of an investigational study drug for Pruritus (“Itch”) Relief.

The KPL-716-C201 Study is evaluating if an investigational medication is safe and effective for those with moderate to severe prurigo nodularis.

Chronic itch associated with Prurigo Nodularis

We are searching for individuals to participate in a clinical trial testing the safety and efficacy of an investigational drug when used for the treatment of PN itch.  

The purpose of the PRISM Study, is to test the safety and effectiveness of an investigational study drug fro Pruritus ("Itch") Relief.  

This study is testing the efficacy and safety of an oral medication in patients with Prurigo Nodularis for pruritis (severe itch) relief.  

Can’t stop scratching because of bumps that itch? You may have prurigo nodularis!